Eiichi Imai Selected Research

Quinuclidines

1/2002	General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 4th communication: Effects on gastrointestinal, urinary and reproductive systems and other effects.
1/2002	General pharmacological profile of the novel muscarinic receptor agonist SNI-2011, a drug for xerostomia in Sjögren's syndrome. 1st communication: effects on general behavior and central nervous system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eiichi Imai Research Topics

Disease

2	Xerostomia 01/2002 - 01/2002
1	Liver Failure 08/2002
1	Mydriasis 01/2002
1	Tremor (Tremors) 01/2002
1	Ulcer 01/2002
1	Hypothermia 01/2002

Drug/Important Bio-Agent (IBA)

2	cevimeline (Evoxac)FDA Link 01/2002 - 01/2002
2	QuinuclidinesIBA 01/2002 - 01/2002
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2002 - 01/2002
1	MonocrotalineIBA 08/2002
1	Dihydrotachysterol (AT 10)IBA 01/2002
1	Charcoal (Charbon)IBA 01/2002

Therapy/Procedure

1	Oral Administration 01/2002
1	Analgesia 01/2002